Multicenter, single-arm phase II clinical study of induction treatment followed by surgery combined with adjuvant radiochemotherapy and maintenance therapy for stage III unresectable or borderline resectable NSCLC (N2b or N3)

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: bc98a2b5d27eb2a8a3960042499dbb4a91ed6498
First added on: Oct 10, 2026